The current institutional shareholding score of Aurinia Pharmaceuticals Inc is 5.00, ranking 133 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 58.21%, representing a quarter-over-quarter increase of 18.24%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.27% of shares outstanding, with 1.84% decrease in holdings.